Wall Street Signals: GB Sciences, CEO, John Poss, Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast

GB Sciences, CEO, John Poss, Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast


GB Sciences, Inc. (OTCQB: GBLX) ("the "Organization"), today reported CEO, John Poss, came back to Uptick Newswire's "Stock Day" podcast with Everett Jolly for an operational refresh.

"GB Sciences is a cannabis-based therapeutic think-tank," said Jolly. "It has manufactured a solid business mark, which enables the Company to subsidize inquire about. John Poss goes along with us today to talk about the numerous things that have happened as of late."

The Company is at present in 30-day due industriousness period for the obtaining of Nevada Pure. Moreover, GB Sciences is wanting to record an Exploratory IND with a specific end goal to start an in-human trial for a Parkinson's treatment. "We are energized for what the year will bring," said Poss. "We plan to have FDA endorsement for our Parkinson's trail by December of this current year. The procurement of Nevada Pure would achieve $16 million to our main concern and we have until April 26th to conclude the buy; in all, we are amped up for 2018."

To tune in to the full meeting please click here to the accompanying connection: https://upticknewswire.com/highlighted talk with president john-poss-of-gb-sciences-inc-otcqb-gblx-4/ 

About GB Sciences, Inc. 

GB Sciences, Inc. (OTCQB: GBLX) is an assorted cannabis organization, concentrated on institutionalized development and generation strategies; and also biopharmaceutical innovative work. The Company's objective is making sheltered, institutionalized, pharmaceutical-review, cannabinoid treatments that objective an assortment of therapeutic conditions. To take in more about GB Sciences, Inc., go to http://gbsciences.com.

Forward-Looking Statements 

This public statement may contain proclamations identifying with future outcomes or occasions, which are forward-looking articulations. Words, for example, "expects", "means", "plans", "may", "could", "should", "envisions", "likely", "accepts" and expressions of comparative import may recognize forward-looking proclamations. These announcements are not recorded certainties, but rather speak to just the Company's conviction in regards to future occasions, a considerable lot of which, by their inclination, are innately unverifiable and outside of the Company's control. It is conceivable that the Company's real outcomes and budgetary condition may contrast, potentially substantially, from the expected outcomes and money related condition showed in these forward-looking articulations. Further, data concerning the Company and its business, including factors that possibly could physically influence the Company's business and monetary and different outcomes, are contained in the Company's filings with the Securities and Exchange Commission, accessible at www.sec.gov. All forward-looking proclamations incorporated into this official statement are made just as of the date of this public statement, and we don't attempt any commitment to freely refresh or adjust any forward-looking articulations to reflect occasions or conditions that in this way happen or of which we from now on end up mindful.

Note: Although the Company's innovative work exercises are not illicit, the generation and offer of cannabis items disregard government laws as they directly exist.

Contact Information

Corporate: 

GB Sciences, Inc., 3550 West Teco Ave., Las Vegas, NV 89118

866-721-0297, or

Tom Arcuragi, EVP, tom@gbsciences.com